|Intercept Pharmaceuticals Initiates Phase 1 Study of INT-767, a Dual FXR and ...|
OCA is being developed for a variety of chronic liver diseases, including primary biliary cirrhosis, recently renamed primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. The ...
GlobeNewswire (press release) - Mon, 30 Nov 2015 13:00
|Insider Selling: Intercept Pharmaceuticals Inc (ICPT) Insider Sells 1150 ...|
Dakota Financial News - Tue, 01 Dec 2015 05:07
|Lisa Bright, an Insider in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Sold ...|
FinancialMagazin.com - Mon, 30 Nov 2015 20:30
|Intercept Pharmaceuticals Inc (ICPT) Files Form 4 Insider Selling : Lisa ...|
Insider Trading Report - Mon, 30 Nov 2015 18:03
|Technical report examines strategies to identify biliary atresia|
A new AAP technical report describes potential screening strategies for early identification of biliary atresia, the most common cause of pediatric end-stage liver disease and the leading indicator for pediatric liver transplantation. The technical ...
AAP News - Mon, 30 Nov 2015 04:22
|Family of seven-month-old diagnosed with rare liver disease to hold ...|
A seven-month-old baby has received a life-saving liver transplant from her cousin. Tiffany Lothian, from Carshalton, was diagnosed with a rare liver disease Biliary Atresia at 6-weeks-old. In amongst all the hospital visits, check-ups and family ...
Sutton Guardian - Sun, 22 Nov 2015 21:03
|Intercept Presents New PBC Data at AASLD 2015|
... underserved liver diseases, today announced results from three studies in primary biliary cirrhosis, recently renamed primary biliary cholangitis (PBC), that will be presented at the American Academy for the Study of Liver Diseases (AASLD) Annual ...
GlobeNewswire (press release) - Sat, 14 Nov 2015 11:07
|Intercept Presents New Data Analyses on Non-Invasive Liver Testing From FLINT ...|
Nasdaq - Sat, 14 Nov 2015 07:00
|Viral hepatitis: The silent killer you need to keep at bay|
The Delhi government, in order to create awareness among the masses about the disease and its symptoms (that is often mild), celebrates December 4 as Hepatitis day every year. The government-run Institute of Liver and Biliary Sciences (ILBS) will ...
Hindustan Times - Sat, 28 Nov 2015 22:56
|Obeticholic Acid Promising for Biliary Cholangitis Long-term|
SAN FRANCISCO — Obeticholic acid maintains reduced levels of key biomarkers for primary biliary cholangitis (previously known as primary biliary cirrhosis) for up to 5 years, according to the results of a new study. "As a long-term therapy, both as ...
Medscape - Sun, 15 Nov 2015 13:33
|PBC Drug Lowers ALP|
A novel recombinant variant of fibroblast growth factor 19 that modifies bile acid synthesis improved alkaline phosphatase (ALP) levels in patients with primary biliary cholangitis (PBC; formerly known as primary biliary cirrhosis). ... there was a ...
MedPage Today - Tue, 17 Nov 2015 07:36
|Liver transplant survivor Rachel Powell is finally looking forward to a ...|
Four years ago Rachel Powell was facing a miserable Christmas , sat waiting for the phone to ring, knowing her liver was on the verge of failing and only a transplant could save her. The 45-year-old had been diagnosed with a rare and incurable illness ...
WalesOnline - Wed, 25 Nov 2015 08:28